These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20049837)

  • 21. EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy.
    Uhlyarik A; Piurko V; Papai Z; Raso E; Lahm E; Kiss E; Sikter M; Vachaja J; Kenessey I; Timar J
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32155907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of EGFR/pi3k/Akt signaling pathway in seminomas.
    Guerra F; Quintana S; Giustina S; Mendeluk G; Jufe L; Avagnina MA; Díaz LB; Palaoro LA
    Biotech Histochem; 2021 Feb; 96(2):125-137. PubMed ID: 32597316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-216b Targets FGFR1 and Confers Sensitivity to Radiotherapy in Pancreatic Ductal Adenocarcinoma Patients Without EGFR or KRAS Mutation.
    Egeli U; Tezcan G; Cecener G; Tunca B; Demirdogen Sevinc E; Kaya E; Ak S; Dundar HZ; Sarkut P; Ugras N; Yerci O; Ozen Y; Evrensel T
    Pancreas; 2016 Oct; 45(9):1294-302. PubMed ID: 27101576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of
    Koulouridi A; Karagianni M; Messaritakis I; Sfakianaki M; Voutsina A; Trypaki M; Bachlitzanaki M; Koustas E; Karamouzis MV; Ntavatzikos A; Koumarianou A; Androulakis N; Mavroudis D; Tzardi M; Souglakos J
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New Classification for Advanced Colorectal Cancer Using CancerPlex®Genomic Tests].
    Kameyama H; Shimada Y; Ichikawa H; Nagahashi M; Sakata J; Kobayashi T; Nogami H; Maruyama S; Takii Y; Okuda S; Ling Y; Izutsu H; Kodama K; Nakada M; Wakai T
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1361-1365. PubMed ID: 27899776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Dako EGFR pharmDx kit and Zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma.
    Buckley AF; Kakar S
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):305-9. PubMed ID: 17721276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of KRAS Mutations on Management of Colorectal Carcinoma.
    Sullivan KM; Kozuch PS
    Patholog Res Int; 2011 Mar; 2011():219309. PubMed ID: 21437184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer.
    Knickelbein K; Zhang L
    Genes Dis; 2015 Mar; 2(1):4-12. PubMed ID: 25815366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling.
    Tintelnot J; Metz S; Trentmann M; Oberle A; von Wenserski L; Schultheiß C; Braig F; Kriegs M; Fehse B; Riecken K; Bokemeyer C; Stein A; Binder M
    Front Oncol; 2019; 9():1559. PubMed ID: 32039027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of resistance to anti-EGFR therapy in colorectal cancer.
    Shaib W; Mahajan R; El-Rayes B
    J Gastrointest Oncol; 2013 Sep; 4(3):308-18. PubMed ID: 23997942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.
    Chergui F; Chrétien AS; Bouali S; Ramacci C; Rouyer M; Bastogne T; Genin P; Leroux A; Merlin JL
    Clin Chem; 2009 Jul; 55(7):1327-36. PubMed ID: 19443568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment.
    Lyu N; Pedersen B; Shklovskaya E; Rizos H; Molloy MP; Wang Y
    Exploration (Beijing); 2022 Jun; 2(3):20210176. PubMed ID: 37323700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for PML-RARa bcr1 fusion gene in colorectal cancer.
    Herreros-Villanueva M
    Mol Biol Rep; 2012 May; 39(5):5387-91. PubMed ID: 22167334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic characterization of the novel, non-hotspot oncogenic KRAS mutants E31D and E63K.
    Angeles AKJ; Yu RTD; Cutiongco-De La Paz EM; Garcia RL
    Oncol Lett; 2019 Jul; 18(1):420-432. PubMed ID: 31289513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors.
    Strippoli A; Cocomazzi A; Basso M; Cenci T; Ricci R; Pierconti F; Cassano A; Fiorentino V; Barone C; Bria E; Ricci-Vitiani L; Tortora G; Larocca LM; Martini M
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment.
    Dias Carvalho P; Guimarães CF; Cardoso AP; Mendonça S; Costa ÂM; Oliveira MJ; Velho S
    Cancer Res; 2018 Jan; 78(1):7-14. PubMed ID: 29263151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study.
    Ludovini V; Chiari R; Tomassoni L; Antonini C; Baldelli E; Baglivo S; Siggillino A; Tofanetti FR; Bellezza G; Hodge KA; Petricoin E; Pierobon M; Crinò L; Bianconi F
    Oncotarget; 2017 Oct; 8(47):83343-83353. PubMed ID: 29137348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor RAS Gene Expression Levels Are Influenced by the Mutational Status of RAS Genes and Both Upstream and Downstream RAS Pathway Genes.
    Stephens RM; Yi M; Kessing B; Nissley DV; McCormick F
    Cancer Inform; 2017; 16():1176935117711944. PubMed ID: 28634423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere length regulation through epidermal growth factor receptor signaling in cancer.
    Augustine T; Maitra R; Goel S
    Genes Cancer; 2017 May; 8(5-6):550-558. PubMed ID: 28740573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer.
    Roßner F; Gieseler C; Morkel M; Royer HD; Rivera M; Bläker H; Dietel M; Schäfer R; Sers C
    Oncogenesis; 2016 Jan; 5(1):e187. PubMed ID: 26779809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.